Insights

Innovative Cell Therapies NKGen Biotech specializes in developing cutting-edge autologous, allogeneic, and CAR-NK natural killer cell therapies aimed at neurodegenerative and oncological diseases, presenting opportunities for partnerships in advanced immunotherapy solutions.

Expanding Clinical Presence The company's active participation in high-profile neurological and immunology conferences suggests a growing recognition in the medical community, which could facilitate collaborations and licensing deals for innovative treatments.

Strategic International Growth NKGen has partnered with HekaBio to accelerate regulatory and manufacturing efforts in Japan, indicating a focus on expanding into key global markets, which opens doors for distribution and local partnership opportunities.

Pipeline and Research Focus With multiple presentations and promising data on troculeucel for neurodegenerative diseases, there are opportunities to collaborate on clinical trials, supply chain solutions, and technology licensing for advanced cellular therapeutics.

Financial and Market Potential Although currently smaller in scale, NKGen's revenue and recent funding suggest high-growth potential within the expanding biotech and immunotherapy sectors, making it a compelling partner for technology licensing, R&D collaborations, and strategic investments.

Similar companies to NKGen Biotech, Inc.

NKGen Biotech, Inc. Tech Stack

NKGen Biotech, Inc. uses 8 technology products and services including oEmbed, Google Docs, NetSuite, and more. Explore NKGen Biotech, Inc.'s tech stack below.

  • oEmbed
    Dev Tools
  • Google Docs
    Documentation Tools
  • NetSuite
    E-commerce
  • Microsoft Excel
    Editors
  • Font Awesome
    Font Scripts
  • Google Fonts API
    Font Scripts
  • jQuery
    Javascript Libraries
  • GraphPad Prism
    Visualisation Software

Media & News

NKGen Biotech, Inc.'s Email Address Formats

NKGen Biotech, Inc. uses at least 2 format(s):
NKGen Biotech, Inc. Email FormatsExamplePercentage
FLast@nkgenbiotech.comJDoe@nkgenbiotech.com
91%
First.Last@nkgenbiotech.comJohn.Doe@nkgenbiotech.com
9%
FLast@nkmaxamerica.comJDoe@nkmaxamerica.com
96%
FL@nkmaxamerica.comJD@nkmaxamerica.com
3%
Last.First@nkmaxamerica.comDoe.John@nkmaxamerica.com
1%

Frequently Asked Questions

Where is NKGen Biotech, Inc.'s headquarters located?

Minus sign iconPlus sign icon
NKGen Biotech, Inc.'s main headquarters is located at 3001 Daimler Street Santa Ana, California 92705 United States. The company has employees across 2 continents, including North AmericaAsia.

What is NKGen Biotech, Inc.'s official website and social media links?

Minus sign iconPlus sign icon
NKGen Biotech, Inc.'s official website is nkgenbiotech.com and has social profiles on LinkedInCrunchbase.

What is NKGen Biotech, Inc.'s SIC code NAICS code?

Minus sign iconPlus sign icon
NKGen Biotech, Inc.'s SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does NKGen Biotech, Inc. have currently?

Minus sign iconPlus sign icon
As of June 2026, NKGen Biotech, Inc. has approximately 54 employees across 2 continents, including North AmericaAsia. Key team members include Vice President Of Human Resources: I. C.Vice President Development Operations: P. C.Vice President Technical Operations: Y. K.. Explore NKGen Biotech, Inc.'s employee directory with LeadIQ.

What industry does NKGen Biotech, Inc. belong to?

Minus sign iconPlus sign icon
NKGen Biotech, Inc. operates in the Biotechnology Research industry.

What technology does NKGen Biotech, Inc. use?

Minus sign iconPlus sign icon
NKGen Biotech, Inc.'s tech stack includes oEmbedGoogle DocsNetSuiteMicrosoft ExcelFont AwesomeGoogle Fonts APIjQueryGraphPad Prism.

What is NKGen Biotech, Inc.'s email format?

Minus sign iconPlus sign icon
NKGen Biotech, Inc.'s email format typically follows the pattern of FLast@nkgenbiotech.com. Find more NKGen Biotech, Inc. email formats with LeadIQ.

How much funding has NKGen Biotech, Inc. raised to date?

Minus sign iconPlus sign icon
As of June 2026, NKGen Biotech, Inc. has raised $2M in funding. The last funding round occurred on Jul 14, 2025 for $2M.

When was NKGen Biotech, Inc. founded?

Minus sign iconPlus sign icon
NKGen Biotech, Inc. was founded in 2017.

NKGen Biotech, Inc.

Biotechnology ResearchCalifornia, United States51-200 Employees

NKGen Biotech is a clinical-stage biotechnology company harnessing the power of the body's immune system through the development and commercialization of innovative autologous, allogeneic and CAR-NK natural killer cell therapies to treat neurodegenerative and oncological diseases utilizing our proprietary SNK (super-activated) platform.

The mission of NKGen Biotech is to improve patients' lives in a safe and natural way through innovative cell therapy products and to ultimately become the global leader in immune cell therapeutics.  

More information can be found on our website www.nkgenbiotech.com

Section iconCompany Overview

Headquarters
3001 Daimler Street Santa Ana, California 92705 United States
SIC Code
8733 - Noncommercial Research Organizations
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2017
Employees
51-200

Section iconFunding & Financials

  • $2M

    NKGen Biotech, Inc. has raised a total of $2M of funding over 4 rounds. Their latest funding round was raised on Jul 14, 2025 in the amount of $2M.

  • $25M$50M

    NKGen Biotech, Inc.'s revenue is estimated to be in the range of $25M$50M

Section iconFunding & Financials

  • $2M

    NKGen Biotech, Inc. has raised a total of $2M of funding over 4 rounds. Their latest funding round was raised on Jul 14, 2025 in the amount of $2M.

  • $25M$50M

    NKGen Biotech, Inc.'s revenue is estimated to be in the range of $25M$50M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

ยฉ LeadIQ, Inc. All rights reserved.